20/20 Biolabs Inc. (AIDX)
AIDX trades on Nasdaq in Health Care, Precision Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.3513
-4.02% on the day
Market cap
$4.5M
Nano cap
Revenue · 2025
$2.0M
+16.7% on 2024
Net income · 2025
-$3.7M
-182.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AIDX on Nasdaq |
| Sector | Health Care |
| Industry | Precision Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001139685 |
| SEC industry code | Services-Testing Laboratories |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.0M |
| Net income | -$3.7M |
| Operating income | -$3.3M |
| Net margin | -182.8% |
| Operating margin | -162.9% |
| Revenue growth | +16.7% |
| Cash | $1.0M |
| Total assets | $4.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B3 | 2026-08-17 |
| Latest annual report ANNUAL REPORT | 10-K | 2026-03-31 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-14 |
| Latest current report CURRENT REPORT | 8-K | 2026-09-18 |
| Latest proxy PRELIMINARY PROXY STATEMENT | PRE 14A | 2026-10-06 |
Source: SEC EDGAR submissions feed, 165 recent filings. All filings on EDGAR.
Peers in Precision Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NEO | NeoGenomics Inc. | $16.66 | +2.84% | $2.1B |
| ULS | UL Solutions Inc. | $71.08 | -0.14% | $14.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier